Literature DB >> 34354120

ACE2 protein expression within isogenic cell lines is heterogeneous and associated with distinct transcriptomes.

Emily J Sherman1, Brian T Emmer2.   

Abstract

The membrane protein angiotensin-converting enzyme 2 (ACE2) is a physiologic regulator of the renin-angiotensin system and the cellular receptor for the SARS-CoV-2 virus. Prior studies of ACE2 expression have primarily focused on mRNA abundance, with investigation at the protein level limited by uncertain specificity of commercial ACE2 antibodies. Here, we report our development of a sensitive and specific flow cytometry-based assay for cellular ACE2 protein abundance. Application of this approach to multiple cell lines revealed an unexpected degree of cellular heterogeneity, with detectable ACE2 protein in only a subset of cells in each isogenic population. This heterogeneity was mediated at the mRNA level by transcripts predominantly initiated from the ACE2 proximal promoter. ACE2 expression was heritable but not fixed over multiple generations of daughter cells, with gradual drift toward the original heterogeneous background. RNA-seq profiling identified distinct transcriptomes of ACE2-expressing relative cells to non-expressing cells, with enrichment in functionally related genes and transcription factor target sets. Our findings provide a validated approach for the specific detection of ACE2 protein at the surface of single cells, support an epigenetic mechanism of ACE2 gene regulation, and identify specific pathways associated with ACE2 expression in HuH7 cells.
© 2021. The Author(s).

Entities:  

Year:  2021        PMID: 34354120     DOI: 10.1038/s41598-021-95308-9

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  61 in total

1.  The embryonic origin of endocrine cells of the gastrointestinal tract.

Authors:  A Andrew; B Kramer; B B Rawdon
Journal:  Gen Comp Endocrinol       Date:  1982-06       Impact factor: 2.822

2.  Characterization of two new electrophoretic variants of human triosephosphate isomerase: stability, kinetic, and immunological properties.

Authors:  J Asakawa; H W Mohrenweiser
Journal:  Biochem Genet       Date:  1982-02       Impact factor: 1.890

3.  Angiotensin-(1-7) attenuates lung fibrosis by way of Mas receptor in acute lung injury.

Authors:  Qiuhua Chen; Yi Yang; Yingzi Huang; Chun Pan; Ling Liu; Haibo Qiu
Journal:  J Surg Res       Date:  2013-07-17       Impact factor: 2.192

4.  Angiotensin-(1-7) protects from experimental acute lung injury.

Authors:  Nadine Klein; Florian Gembardt; Stephanie Supé; Stephanie M Kaestle; Hannah Nickles; Lasti Erfinanda; Xiaohong Lei; Jun Yin; Liming Wang; Michael Mertens; Katalin Szaszi; Thomas Walther; Wolfgang M Kuebler
Journal:  Crit Care Med       Date:  2013-11       Impact factor: 7.598

5.  Angiotensin-converting enzyme 2 protects from severe acute lung failure.

Authors:  Yumiko Imai; Keiji Kuba; Shuan Rao; Yi Huan; Feng Guo; Bin Guan; Peng Yang; Renu Sarao; Teiji Wada; Howard Leong-Poi; Michael A Crackower; Akiyoshi Fukamizu; Chi-Chung Hui; Lutz Hein; Stefan Uhlig; Arthur S Slutsky; Chengyu Jiang; Josef M Penninger
Journal:  Nature       Date:  2005-07-07       Impact factor: 49.962

Review 6.  ACE2: Evidence of role as entry receptor for SARS-CoV-2 and implications in comorbidities.

Authors:  Natalia Zamorano Cuervo; Nathalie Grandvaux
Journal:  Elife       Date:  2020-11-09       Impact factor: 8.140

7.  Angiotensin-(1-7) improves oxygenation, while reducing cellular infiltrate and fibrosis in experimental Acute Respiratory Distress Syndrome.

Authors:  Vanessa Zambelli; Giacomo Bellani; Roberto Borsa; Federico Pozzi; Alice Grassi; Margherita Scanziani; Vittoria Castiglioni; Serge Masson; Alessandra Decio; John G Laffey; Roberto Latini; Antonio Pesenti
Journal:  Intensive Care Med Exp       Date:  2015-02-27

Review 8.  ACE2, a new regulator of the renin-angiotensin system.

Authors:  Louise M Burrell; Colin I Johnston; Christos Tikellis; Mark E Cooper
Journal:  Trends Endocrinol Metab       Date:  2004 May-Jun       Impact factor: 12.015

9.  An interactive web-based dashboard to track COVID-19 in real time.

Authors:  Ensheng Dong; Hongru Du; Lauren Gardner
Journal:  Lancet Infect Dis       Date:  2020-02-19       Impact factor: 25.071

10.  SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.

Authors:  Markus Hoffmann; Hannah Kleine-Weber; Simon Schroeder; Nadine Krüger; Tanja Herrler; Sandra Erichsen; Tobias S Schiergens; Georg Herrler; Nai-Huei Wu; Andreas Nitsche; Marcel A Müller; Christian Drosten; Stefan Pöhlmann
Journal:  Cell       Date:  2020-03-05       Impact factor: 41.582

View more
  9 in total

Review 1.  The Endolysosomal System: The Acid Test for SARS-CoV-2.

Authors:  Daniella Cesar-Silva; Filipe S Pereira-Dutra; Ana Lucia Moraes Giannini; Cecília Jacques G de Almeida
Journal:  Int J Mol Sci       Date:  2022-04-20       Impact factor: 6.208

2.  TMPRSS2 Expression and Activity Modulation by Sex-Related Hormones in Lung Calu-3 Cells: Impact on Gender-Specific SARS-CoV-2 Infection.

Authors:  Donatella Treppiedi; Giusy Marra; Genesio Di Muro; Rosa Catalano; Federica Mangili; Emanuela Esposito; Anna Maria Barbieri; Maura Arosio; Giovanna Mantovani; Erika Peverelli
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-31       Impact factor: 6.055

3.  Kite-Shaped Molecules Block SARS-CoV-2 Cell Entry at a Post-Attachment Step.

Authors:  Shiu-Wan Chan; Talha Shafi; Robert C Ford
Journal:  Viruses       Date:  2021-11-19       Impact factor: 5.048

Review 4.  The Future of the COVID-19 Pandemic: How Good (or Bad) Can the SARS-CoV2 Spike Protein Get?

Authors:  Matthew A Nugent
Journal:  Cells       Date:  2022-03-02       Impact factor: 6.600

5.  Spike protein of SARS-CoV-2 suppresses gonadotrophin secretion from bovine anterior pituitaries.

Authors:  Dimas Arya Abdillah; Onalenna Kereilwe; Raihana Nasrin Ferdousy; Risa Saito; Hiroya Kadokawa
Journal:  J Reprod Dev       Date:  2022-01-27       Impact factor: 2.214

6.  Identification of cell type specific ACE2 modifiers by CRISPR screening.

Authors:  Emily J Sherman; Carmen Mirabelli; Vi T Tang; Taslima G Khan; Kyle Leix; Andrew A Kennedy; Sarah E Graham; Cristen J Willer; Andrew W Tai; Jonathan Z Sexton; Christiane E Wobus; Brian T Emmer
Journal:  PLoS Pathog       Date:  2022-03-01       Impact factor: 6.823

Review 7.  Cell and Animal Models for SARS-CoV-2 Research.

Authors:  Eloïne Bestion; Philippe Halfon; Soraya Mezouar; Jean-Louis Mège
Journal:  Viruses       Date:  2022-07-09       Impact factor: 5.818

8.  A Newly Engineered A549 Cell Line Expressing ACE2 and TMPRSS2 Is Highly Permissive to SARS-CoV-2, Including the Delta and Omicron Variants.

Authors:  Ching-Wen Chang; Krishna Mohan Parsi; Mohan Somasundaran; Emma Vanderleeden; Ping Liu; John Cruz; Alyssa Cousineau; Robert W Finberg; Evelyn A Kurt-Jones
Journal:  Viruses       Date:  2022-06-23       Impact factor: 5.818

9.  Characterization of ACE2 naturally occurring missense variants: impact on subcellular localization and trafficking.

Authors:  Sally Badawi; Feda E Mohamed; Nesreen R Alkhofash; Anne John; Amanat Ali; Bassam R Ali
Journal:  Hum Genomics       Date:  2022-09-02       Impact factor: 6.481

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.